Previous Article | Next Article 
Journal of Bacteriology, May 1999, p. 2816-2822, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identification of Metal Ligands in the
Clostridium histolyticum ColH Collagenase
Chang-Min
Jung,1
Osamu
Matsushita,1
Seiichi
Katayama,1
Junzaburo
Minami,1
Jun
Sakurai,2 and
Akinobu
Okabe1,*
Department of Microbiology, Faculty of
Medicine, Kagawa Medical University, Kagawa
761-0793,1 and Department of
Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri
University, Tokushima 770-8514,2 Japan
Received 27 July 1998/Accepted 26 February 1999
 |
ABSTRACT |
A Clostridium histolyticum 116-kDa collagenase has an
H415EXXH motif but not the third zinc ligand, as found in
already characterized zinc metalloproteinases. To identify its
catalytic site, we mutated the codons corresponding to the three
conserved residues in the motif to other amino acid residues. The
mutation affecting His415 or His419 abolished
catalytic activity and zinc binding, while that affecting Glu416 did the former but not the latter. These results
suggest that the motif forms the catalytic site. We also mutated the
codons corresponding to other amino acid residues that are likely zinc ligands. The mutation affecting Glu447 decreased markedly
both the enzymatic activity and the zinc content, while that affecting
Glu446 or Glu451 had smaller effects on
activity and zinc binding. These mutations caused a decrease in
kcat but no significant change in
Km. These results are consistent with the
hypothesis that Glu447 is the third zinc ligand. The
spacing of the three zinc ligands is the same in all known clostridial
collagenases but not in other known gluzincins, indicating that they
form a new gluzincin subfamily. The effects of mutations affecting
Glu446 and Glu451 suggest that the two
residues are also involved in catalysis, possibly through an
interaction with the two zinc-binding histidine residues.
 |
INTRODUCTION |
The Clostridium
histolyticum collagenase has been widely used for the
disintegration of connective tissue and separation of tissue culture
cells, because of its broad substrate specificity and its abundance in
culture filtrates (31). However, at least six different
forms with molecular masses ranging from 68 to 125 kDa are present in a
commercial preparation (6, 7). The difficulty in separating
individual enzymes and the lot-to-lot variation of commercial
collagenase preparations limit its practical use. Cloning, nucleotide
sequence analysis, and recombinant DNA technology of the corresponding
gene(s) would facilitate the purification of the C. histolyticum collagenase and also increase our understanding of
this enzyme.
In a previous study we have cloned and sequenced a colH gene
encoding the 116-kDa collagenase (35). We have identified a collagen-binding domain at the C terminus, which binds to insoluble type I collagen in vitro (22) and also to collagen fibers in vivo (25). Recently we have identified a colG
gene encoding another 116-kDa collagenase and presented evidence
supporting the prediction (8) that multiple forms of the
C. histolyticum collagenase are produced by different genes
that have evolved from one another by gene duplication (21).
The enzymatic properties of the C. histolyticum collagenase
and its isoforms have been extensively studied by other workers
(24). The enzymes cleave peptide bonds on the amino side of
the glycine residue in the PXGP sequence, like other bacterial
collagenases (27). Studies by atomic absorption
spectrophotometry and metal replacement with chelators have shown that
all isoforms contain one catalytically essential zinc atom per molecule
(2, 6), so they are considered to be zinc
metalloproteinases. Chemical modification studies have demonstrated
that all the forms share functionally essential aspartate or glutamate
and tyrosine residues (5).
In a previous study we have shown that the N-terminal 80-kDa domain of
ColH degrades the water-soluble substrates, gelatin, and Pz peptide
(4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg) (Sigma
Chemical Co., St. Louis, Mo.), suggesting that it contains the
catalytic site (22). This peptide contains the sequence HEXXH, the zincin consensus motif, which is present in most zinc metalloproteinases (zincins) except for some enzymes containing the
HXXEH, HXXE, or HXH sequence (Fig. 1A).
The motif is conserved in three clostridial collagenases, ColH, ColG
(21), and ColA (23), as shown in Fig. 1B. Thus,
these clostridial collagenases seem to belong to the zincin
superfamily, which includes the vertebrate collagenases (matrix
metalloproteinases [MMPs] 1, 8, and 13) as the matrixin subfamily
(Fig. 1A). Although a three-dimensional structure has been well defined
for the N-terminal catalytic domains of these vertebrate collagenases
and the full-length MMP-1 (4, 12, 20, 28), these MMPs do not
show significant homology to the clostridial collagenases. Moreover,
the clostridial collagenases do not share the third zinc-binding
residue conserved in the metalloproteinases of the metzincin family, a
histidine residue at position +11, or that in the gluzincin family, a
glutamate residue at position +24, +25, +29, or +64 (note that these
coordinates are numbered in respect to the first zinc-binding histidine
residue [Fig. 1A]). The alignment of the amino acid sequences of the
three collagenases reveals that they conserve the sequence
E446(D in the case of
ColG)E447XXXE451 C-terminal to the zincin motif
(Fig. 1B). This leads us to suspect that any one of the glutamate
residues could be the third zinc ligand. Furthermore, the spacing
between the latter two glutamate residues is comparable to that between
the glutamate and aspartate residues in the EXXXD sequence of
thermolysin, which is located C-terminal to the zincin motif with a gap
of 19 residues.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 1.
Families of zinc metallopeptidases and alignment of
amino acid sequences around the putative zinc-binding residues of
clostridial collagenases. (A) The families of the zinc
metallopeptidases and their interrelationships are based on the
sequence around the zinc binding residues (15). The
zinc-binding amino acid residues are numbered on the top. Numbers refer
to the position relative to the first zinc-binding amino acid residue.
(B) Amino acid sequence alignment of three clostridial collagenases,
ColA (23), ColG (21), and ColH (35).
The boxed residue indicates tyrosine conserved in the three
collagenases, which is suggested for thermolysin to stabilize the
catalytic intermediate (see Discussion). Arrows indicate the positions
of the third zinc ligands in thermolysin and metzincins. Arrowheads
indicate the amino acid residues of ColH that are changed, and the
positions relative to the N-terminal residue are numbered underneath
the ColH sequence. NEP, neutral endopeptidase 24.11; ACE, angiotensin
I-converting enzyme; APA, aminopeptidase A.
|
|
Identifying and characterizing the catalytic center of ColH is a
prerequisite for the elucidation of the mechanism underlying the
hydrolysis of triple-helical collagen molecules by this enzyme. Thus,
we constructed various ColH mutants with mutations in residues presumed
to form the active site and examined the effects of the mutations on
zinc retention and enzymatic activity. First, we characterized
His415, Glu416, and His419 mutants
to examine whether the HEXXH motif forms the catalytic center. Second,
we constructed mutants with mutations in candidates for the third zinc
ligand, one asparagine and three glutamate residues at positions 439, 446, 447, and 451, respectively (Fig. 1B). In this paper, we propose a
new subfamily of gluzincins and discuss a possible role for the
glutamate residues around the third zinc ligand in the formation of the
catalytic center of clostridial collagenases.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmid.
Escherichia coli DH5
(3, 13) and the plasmid pBluescript II KS(+) (1)
were used as the host and vector for the construction of recombinant
plasmids, respectively. To express wild-type and mutated
colH genes, we used an E. coli-Bacillus subtilis
shuttle vector, pAT19 (32), and the hosts E. coli
DH5
and B. subtilis DB104 (his nprR2 nprE18
aprD3) (17).
Construction of plasmid encoding wild-type ColH.
A 4-kb
BssHII fragment containing a full-length colH
gene was isolated from plasmid pCHC208 (16), filled in with
Klenow enzyme, and inserted into the SmaI site of pAT19. The
resultant plasmid, which contained the colH gene in the same
direction as the lacZ
gene, was designated pJCM600. This
plasmid was used for the preparation of wild-type ColH and also for the
construction of plasmids expressing mutant colH genes
mutated at codons corresponding to the HEXXH motif.
Site-directed mutagenesis.
Mutagenesis was performed by
using the Transformer site-directed mutagenesis kit (CLONTECH
Laboratories, Inc., Palo Alto, Calif.) according to the instructions of
the manufacturer. Plasmid pCHC201, which bears a 2.8-kb
HaeIII-PstI fragment encoding segments 1 and 2a
of ColH in pBluescript II KS(+) (22), was used as the template for mutagenesis. The mutagenic primers used in this study are
listed in Table 1, and
5'-GTGACTGGTGAGGCCTCAACCAAGTC-3' was used as the selection
primer. Mutations were identified by nucleotide sequencing, which was
performed by using the ABI Prism BigDye terminator cycle sequencing
ready reaction kit with AmpliTaq DNA polymerase FS (Perkin-Elmer,
Foster City, Calif.) and a synthetic primer,
5'-ACAACAGTCCCGAAGAAT-3', on a Perkin-Elmer 377 DNA
sequencer.
Construction of plasmids encoding mutant ColH proteins.
Plasmid derivatives to produce the enzymes with H415A, H415F, E416D,
E416Q, and H419R mutations (Fig. 1) were constructed as follows (Fig.
2A). A 3-kb BssHII fragment
containing the colH gene truncated at the 3'-terminal side
was isolated from each pCHC201 mutant derivative, filled in, and
ligated into the SmaI site of plasmid pAT19. These plasmids
were designated the pJCM700 series. A 3-kb PstI fragment was
excised from each of these plasmids and used to replace the
PstI fragment of pJCM600. The resultant plasmids were
designated the pJCM800 series.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Schematic overview of plasmids used for production of
mutant ColH enzymes. (A) Plasmid derivatives for construction of mutant
ColH enzymes, in which amino acid residues within the HEXXH motif were
replaced with other amino acid residues. (B) Plasmid derivatives for
construction of mutant ColH enzymes, in which the putative third
zinc-ligating residue was replaced with other amino acid residues.
Shown are plasmid DNA (thin bar), the colH gene (open box),
a region encoding the putative zinc-ligating residues (solid box), and
a region with a point mutation (*). B, BamHI; Bs,
BssHII; Bt, BstXI; E, EcoRI; RV,
EcoRV; H, HaeIII; P, PstI; S,
SmaI; Sa, SacII.
|
|
In order to facilitate the construction of the other mutant enzymes
(with N439A, E446Q, E446A, E446D, E447Q, E447A, E447D,
E451Q, E451A,
and E451D mutations), a 200-bp
BstXI-
EcoRI
fragment
was used as a mutation cassette (Fig.
2B). Plasmid pCHC208 was
digested with
SacII, followed by removal of the 3' overhangs
with
T4 DNA polymerase and by religation, which resulted in the removal
of a
BstXI site that overlapped the
SacII site in
the vector.
The resultant plasmid, named pCHC208

Bt, has a
BstXI site within
the
colH gene. A 4-kb
BssHII fragment isolated from pCHC208

Bt
was inserted into
the
SmaI site of pAT19

E, a pAT19-derived plasmid
lacking
the unique
EcoRI site. The resulting plasmid, named
pJCM600

EBt,
contained only one
BstXI site and one
EcoRI site in the
colH gene.
A 200-bp
BstXI-
EcoRI fragment of pJCM600

EBt was
replaced with
the corresponding fragment isolated from each of the
pCHC201 mutant
derivatives, and the resulting plasmids were designated
the pJCM900
series. After all the plasmids of the pJCM800 and pJCM900
series
had been examined for the correct construction by nucleotide
sequencing,
they were used to transform
B. subtilis DB104 as
described previously
(
16).
DNA manipulations.
Restriction endonucleases were purchased
from Takara Shuzo (Kyoto, Japan), Toyobo (Osaka, Japan), and New
England Biolabs (Beverly, Mass.). The DNA ligation kit and DNA blunting
kit were products of Takara Shuzo. All recombinant DNA procedures were carried out as described by Sambrook et al. (30).
Purification of wild-type and mutant ColH proteins.
Wild-type and mutant ColH enzymes were purified from cultures of
recombinant strains of either B. subtilis DB104 or E. coli DH5
. All recombinant B. subtilis strains were
grown in MLSE8 broth (10 g of Bactotrypton [Difco Laboratories,
Detroit, Mich.] per liter, 5 g of yeast extract [Difco] per
liter, 5 g of NaCl per liter, 2 g of glucose per liter,
135 g of sodium succinate hexahydrate per liter, and 0.008 g of
erythromycin per liter). Cultures were started by inoculating 1 ml of a
preculture into each of four 500-ml flasks containing 200 ml of broth.
After incubating for 7 h at 37°C with shaking at 100 rpm, cells
were removed by centrifugation at 10,000 × g for 30 min at 4°C. The supernatant was subjected to ammonium sulfate
precipitation, gel filtration, and ion-exchange chromatography as
described previously (16), except that a linear gradient
from 0 to 0.5 M NaCl was used for ion-exchange chromatography. All
recombinant E. coli strains were cultured in two 3-liter
flasks, each containing 1 liter of Luria-Bertani medium supplemented
with 150 µg of erythromycin per ml. Cultures were started with a 1%
inoculum of an overnight preculture and grown for 16 h at 37°C
with shaking at 150 rpm. The cells were collected by centrifugation at
10,000 × g for 20 min at 4°C and resuspended in 200 ml of phosphate-buffered saline. The suspension was treated with
polymyxin B to obtain a periplasmic fraction (26). Fifty
milliliters of a phosphate-buffered saline solution containing 10,000 U
of polymyxin B (Taito Pfizer Ltd., Tokyo, Japan) per ml was added to
the suspension. After being incubated for 30 min at 37°C, the
suspension was centrifuged at 10,000 × g for 30 min at
4°C. The supernatant (the periplasmic fraction) was used to purify
recombinant ColH enzymes. The subsequent purification procedures were
essentially the same as those from the recombinant B. subtilis strains described above.
Enzyme assay and protein determination.
The collagenase
activity was assayed by the Pz peptide (Sigma Chemical Co.) hydrolyzing
method (34). One unit of enzyme activity is defined as the
amount of enzyme which causes an increase of 0.1 A320 unit per min. For kinetics studies, the
assay was carried out with varying concentrations (0.05 to 0.32 mM) of
the substrate. The activity unit was converted on the basis of an observed value of the molecular extinction coefficient at 320 nm of
phenylazobenzyloxycarbonyl-Phe-Leu (Bachem, Budendorf, Switzerland) in
ethylacetate (
= 20.67 cm/mM), and the data were displayed as a
Lineweaver-Burk plot, from which the Km and
kcat values were calculated by the least-squares
method. The collagenase activities of some ColH mutants were also
assayed by using collagen from bovine achilles tendon (CLSPA;
Worthington Biochemical Co., Freehold, N.J.) according to the
instruction manual from the supplier. Briefly, 25 mg of collagen and 5 ml of a reaction buffer [50 mM
N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid-NaOH
buffer (pH 7.5) containing 0.36 mM CaCl2] were placed into
each test tube, and collagen was swollen by incubating at 15°C for 15 min. One unit of enzyme activity equals 1 µmol of L-leucine equivalents liberated from collagen in 5 h
at 37°C (pH 7.5) under the specified conditions. Protein
concentrations were determined by the method of Bradford (9)
with the Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond,
Calif.) and bovine serum albumin as a standard. All the assays were
carried out in triplicate.
SDS-PAGE and N-terminal amino acid sequencing.
The purities
of wild-type and mutant ColH enzymes were examined by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were
separated on a 7.5% polyacrylamide gel and stained with Coomassie
brilliant Blue R (18). The N-terminal amino acid sequence of
purified recombinant wild-type ColH was determined on an automatic
protein sequencer (model 492; Perkin-Elmer) as described previously
(22).
Determination of zinc content in wild-type and mutant ColH
proteins.
The amount of zinc was determined with an atomic
absorption spectrophotometer (model Z-8200; Hitachi, Tokyo, Japan) and
a zinc standard solution (Wako Pure Chemicals, Osaka, Japan). The results obtained from each batch of wild-type or mutant enzyme were
averages of two determinations. All solutions were prepared in
plasticware with Nanopure water (Barnstead, Dubuque, Iowa).
 |
RESULTS |
Mutagenesis of colH and purification of mutant
enzymes.
We employed a shuttle vector plasmid, pAT19, and the
B. subtilis host for the production of wild-type ColH. The
recombinant enzyme with an apparent molecular mass of 116 kDa was
purified to homogeneity based on SDS-PAGE analysis (data not shown).
The specific activity of the purified recombinant ColH was 1,238 ± 45 (the mean ± standard deviation) U/mg of protein. Some of
the plasmid constructs carrying the mutant colH genes were
successfully introduced into B. subtilis DB104, and the
transformants were used for the purification of enzymes with H415F,
E416D, H419R, E446Q, E447Q, and E451Q mutations. They were also
purified to apparent homogeneity based on SDS-PAGE analysis (data not
shown). The transformation of B. subtilis DB104 with
plasmids encoding the other mutant enzymes (with H415A, E416Q, N439A,
E446A, E446D, E447A, E447D, E451A, and E451D mutations) was
unsuccessful. Therefore, we purified these mutant ColH enzymes as well
as the wild type from the periplasmic fractions of E. coli
transformants. The specific activity of wild-type ColH from the
recombinant E. coli was 1,011 ± 34 U/mg of protein.
SDS-PAGE analysis revealed that both the wild-type and mutant
recombinant E. coli enzymes were purified to homogeneity
(data not shown). The N-terminal amino acid sequence of the wild-type
enzyme obtained from E. coli, AVDKNNATA AVQNESKRYTV, was
identical to that from B. subtilis. Furthermore, no Pz
peptidase activity was found in the periplasmic fraction from the
E. coli host strain, and no proteinase activity other than
ColH was detected in the periplasmic fraction from the recombinant
E. coli strain carrying the wild-type colH gene
by gelatin zymography, a sensitive method for the detection of
contaminating proteinase activity.
Identification of the HEXXH sequence as the active site.
The
HEXXH (amino acids 415 to 419) zinc metalloproteinase consensus motif
in ColH predicts that the two histidine residues coordinate a zinc ion
and that the glutamate residue acts as a catalytic base. To test this,
we constructed colH mutants in which the codons
corresponding to the histidine and glutamate residues were individually
mutated. The histidine residue at position 415 was replaced with an
alanine residue which lacks an imidazole ring (H415A). The histidine
residue at position 419 was replaced with an arginine residue which has
a positive charge (H419R). The glutamate residue at position 416 was
replaced with an aspartate residue, in which one methylene group is
removed to shorten the side chain (E416D).
The activities of three enzymes with H415A, E416D, and H419R mutations
against type I insoluble collagen and Pz peptide were
determined and
compared with those of wild-type ColH. The activities
of these mutant
enzymes were reduced to 0.33% ± 0.57%, 3.52% ±
1.76%, and 1.96% ± 0.59% (means ± standard deviations), respectively,
of that of
wild-type ColH when determined on collagen. Their activities
on the Pz
peptide were 0.08% ± 0.02%, 0.23% ± 0.14%, and 0.13%
± 0.06%,
respectively, of that of wild-type ColH. Since the activities
of these
mutant enzymes toward the soluble substrate paralleled
those toward the
insoluble substrate, we used Pz peptide as the
substrate for subsequent
enzyme assays. Two other enzymes with
H415F and H416Q mutations, in
which the histidine residue at position
415 and the glutamine residue
at position 416 were replaced with
phenylalanine and glutamine
residues, respectively, were constructed.
The Pz peptidase activities
of these enzymes were 0.25% ± 0.03%
and 0.23% ± 0.09% (means ± standard deviations), respectively,
of that of wild-type ColH. The
zinc contents of the enzymes with
E416D and E416Q mutations were almost
the same as that of the
wild-type enzyme, which contained approximately
one atom of zinc
per protein, whereas those of the enzymes with H415A,
H415F, and
H419R mutations decreased markedly to less than 50% of that
of
the wild-type enzyme (Table
2). These
results indicate that the
two histidine and the glutamate residues in
the HEXXH motif likely
play a crucial role in catalysis, as observed
for other zincins,
and suggest that the two histidine residues
coordinate a zinc
ion.
Putative identification of the third zinc ligand.
In the
enzymes in the thermolysin family, a glutamate residue (position +25)
serves as the third zinc-binding residue. To examine the possibility
that an asparagine residue (position +25) is the third zinc ligand in
ColH, we constructed an enzyme with an N439A mutation, in which the
side chain of Asn439 is replaced with a hydrogen, and the
enzymatic activity and zinc content of this mutant enzyme were
determined (Table 2 and Table 3). Neither
were affected by this point mutation. The most likely candidate for the
third zinc ligand is one of three glutamate residues at positions 446, 447, and 451, all of which are conserved in ColH and ColA and two of
which are conserved in all three clostridial collagenases. We generated
nine mutations of the codons corresponding to these three glutamate
residues to identify the third zinc ligand: Glu446,
Glu447, and Glu451 were changed to glutamine
(E446Q, E447Q, and E451Q), alanine (E446A, E447A, and E451A), or
aspartate (E446D, E447D, and E451D). The effects of these mutations on
enzymatic activity and zinc coordination were examined (Table 2 and
Table 3). The replacement of Glu447 with an alanine or
glutamine residue reduced markedly both the enzymatic activity and the
zinc content. Even when only one methylene group was removed from the
residue (E447D), both the enzyme activity and zinc coordination were
severely affected. On the other hand, the replacement of
Glu451 with an alanine residue did not affect the zinc
content, although the glutamine residue did slightly. Surprisingly,
these mutations also caused a marked decrease in enzymatic activity,
though not as much as mutations of Glu447 (Table 3).
Mutations affecting Glu446 caused a significant but less
prominent decrease in the enzymatic activity, but they did not affect
the zinc content except for E446A, because of which the zinc content
decreased slightly. Taken together, it is suggested that
Glu447 is a zinc ligand, and it seems likely that
Glu446 and Glu451 do not coordinate a zinc ion
directly but are important for catalytic activity.
Kinetic analysis of the enzymes with Glu446,
Glu447, and Glu451 mutations.
To
characterize more precisely the functions of these three mutants, we
performed kinetics studies of the wild-type enzyme and the enzymes with
E446A, E447Q, and E451A mutations (Table 4). Since the enzyme activity of E447A
was too low, E447Q was used in place of E447A. The
Km values of E446A, E447Q, and E451A calculated
from Lineweaver-Burk plots were similar to that of the wild-type
enzyme, as shown in Table 4. In contrast, the
kcat values of E447Q and E451A were decreased
20- and 15-fold, respectively, and their specificity constants
(kcat/Km) were reduced to
less than 10% of that of the wild-type enzyme. The effect of mutating Glu446 on the catalytic activity was smaller with the
kcat values reduced about fourfold, and the
corresponding specificity constant
(kcat/Km) decreased to
about 20% of that of the wild-type enzyme.
 |
DISCUSSION |
In order to purify and characterize the various mutant ColH
enzymes, we attempted to find an expression system which produces them
in quantity. To solve the problem encountered previously (an E. coli-B. subtilis shuttle vector, pHY300PLK, with the
colH gene was unstable [16]), we used
another shuttle vector, pAT19, which replicates in the theta mode.
Unfortunately, the efficiency of transformation of B. subtilis was too low to obtain cells containing some of the
plasmids. Therefore, these enzymes were obtained from E. coli, although the yield was approximately half of that from B. subtilis. The purities of the enzyme preparations were
the same for both organisms, and they had the same N-terminal amino acid sequence, suggesting that they are synthesized in a similar way.
The recovery of the mutant enzymes was almost the same as that of the
wild-type enzyme in each system, suggesting that the mutations do not
affect the biosynthesis, the folding, or the stability of the mutant enzymes.
The mutation affecting the histidine residues in the HEXXH motif
abolished the enzymatic activity and reduced the zinc binding. The
replacement of Glu416 with a glutamine or an aspartate
residue abolished enzymatic activity. On the basis of crystallographic
studies in related systems, the modification of Glu to an aspartate
residue is expected to move the carboxyl group 1.4 Å further from the
zinc, which would reduce the polarization of the zinc-coordinated water
molecule (33), so it would not be sufficiently activated to
initiate a nucleophilic attack on the substrate carbonyl group
(14). These results indicate that the HEXXH motif likely
forms the catalytic center in ColH, as in other zinc metalloproteinases
which belong to the metzincin and gluzincin families.
Asn439 (at position +25) is unlikely to be the third zinc
ligand, since the N439A mutant exhibited the same enzymatic activity and zinc coordination as the wild type. The glutamate residues at
positions 446, 447, and 451 were replaced with a glutamine residue, a
weaker nucleophile; an alanine residue, a residue unable to make a
coordinate bond or a hydrogen bond; and an aspartate residue, a similar
nucleophile with a shorter side chain. All the mutations decreased
enzymatic activity, with changes of Glu447 exhibiting the
most prominent decrease. The zinc content was reduced in the
Glu447 mutants but less so in the other mutants. These
results indicate that Glu447 is likely to be the third zinc
ligand. The replacement of Glu447 with an alanine residue
decreased the specific activity to 0.7%. Changing the residue to an
aspartate residue (mutant E447D), thus restoring a carboxyl group in
the side chain, did not restore enzymatic activity (0.8%). On the
other hand, the mutation of Glu447 to a glutamine residue
(mutant E447Q) restored activity to 5.1% of that of the wild-type
enzyme. Of the three Glu447 mutants the zinc content is
highest in the enzyme with the E447Q mutation. This restoration may be
due to the carbamoyl group in the glutamine residue which can act as a
weak zinc coordinator.
The fact that the Glu446 and Glu451 mutants
exhibited decreased enzymatic activities suggests a functional role for
their carboxyethyl side chains in the catalytic mechanism. The
Km values of enzymes with E446A and E451A
mutations, which decreased enzymatic activity the most of all the
Glu446 and Glu451 mutants, were not changed
significantly (P, 0.957 and 0.791, respectively), indicating
that their substrate binding is not impaired. Therefore, it seems
unlikely that the mutations alter the global three-dimensional
structure of the enzyme. On the other hand, their
kcat values decreased significantly, indicating
that the catalysis was impaired. Some enzymes in the gluzincin family, such as thermolysin, neutral endopeptidase 24.11, angiotensin I-converting enzyme, and lactococcal endopeptidase, have an aspartate residue on the carboxyl side of the zinc-binding glutamate residue with
a gap of three residues (EXXXD) (19, 29, 33). The role of
the aspartate residue in thermolysin has been identified from the
crystal structure of the enzyme, which reveals that the side chain
forms a salt link with the imidazole ring of the first histidine residue in the HEXXH motif (11). It was also pointed out
that an asparagine residue located on the amino side of the EXXXD
sequence of thermolysin forms a carbonyl-histidine-zinc triad along
with the second histidine residue in the HEXXH motif (10).
The EEXXXE sequence in ColH, in which the second E is probably the
third zinc ligand, is comparable to the NEXXXD sequence in thermolysin, in which E is the third zinc ligand. Thus, the other two glutamate residues in the ColH sequence could form two carboxylate-histidine-zinc triads.
The tyrosine residue(s) has been shown to be essential for the C. histolyticum collagenase by chemical modification studies (5). A tyrosine residue, which is separated by seven
residues from the NEXXXD sequence of thermolysin and is proposed to
interact with a carbonyl oxygen in the tetrahedral intermediate
(14), is also conserved in all of the clostridial
collagenases at eight residues from the EEXXXE sequence (Fig. 1) near
the catalytic site. This reinforces the structural similarity between
thermolysin and ColH near the catalytic site. Based on this similarity
and the results from the mutational analysis, we predict that the catalytic zinc ion in ColH is coordinated by two
glutamate-histidine-zinc triads, one made by Glu446 and
His419 and the other made by Glu451 and
His415, both of which play a critical role in the catalytic
mechanism (Fig. 3).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Proposed structure of the catalytic center of ColH. The
zinc-coordinating bonds and hydrogen bonds are indicated by thick
arrows and dotted lines, respectively. Thin arrows represent the first
steps of the mechanism of action.
|
|
The present study has presented evidence that ColH constitutes a new
subfamily of gluzincin along with the other clostridial collagenases,
ColG and ColA. They do not show any significant similarity to the
vertebrate collagenases in the amino acid sequences of the whole
peptides, catalytic site, or C-terminal domain. The structural
difference can also be predicted from the fact that
-collagenase
corresponding to ColH possesses five Ca atoms per molecule
(24), unlike MMP-1, which contains two Ca atoms per molecule
(20). Therefore, we expect that the two types of
collagenases differ in overall structure. A crystallographic study,
which is now in progress, is a prerequisite to prove our hypothesis. In addition, it would provide insights into the similarity and
dissimilarity of the two types of collagenases.
 |
ACKNOWLEDGMENTS |
We thank David B. Wilson (Section of Biochemistry, Molecular and
Cell Biology, Cornell University, Ithaca, N.Y.) for invaluable discussion and assistance in preparing the manuscript. We also thank
Patrice Courvalin (Unité des Agents Antibactériens,
Institut Pasteur, Paris, France) for providing us with plasmid vector
pAT19. We are indebted to Masahiro Nagahama (Department of
Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri
University, Tokushima, Japan) for the determination of the zinc content
of ColH and its mutant derivatives.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Faculty of Medicine, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan. Phone: 81-87-898-5111. Fax:
81-87-891-2129. E-mail: microbio{at}kms.ac.jp.
 |
REFERENCES |
| 1.
|
Alting-Mees, M. A., and J. M. Short.
1989.
pBluescript II: gene mapping vectors.
Nucleic Acids Res.
17:9494[Free Full Text].
|
| 2.
|
Angleton, E. L., and H. E. Van Wart.
1988.
Preparation and reconstitution with divalent metal ions of class I and class II Clostridium histolyticum apocollagenases.
Biochemistry
27:7406-7412[Medline].
|
| 3.
|
Bethesda Research Laboratories.
1986.
BRL pUC host: E. coli DH5 competent cells.
Focus
8:9.
|
| 4.
|
Bode, W.,
P. Reinemer,
R. Huber,
T. Kleine,
S. Schnierer, and H. Tschesche.
1994.
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
EMBO J.
13:1263-1269[Medline].
|
| 5.
|
Bond, M. D.,
D. R. Steinbrink, and H. E. Van Wart.
1981.
Identification of essential amino acid residues in Clostridium histolyticum collagenase using chemical modification reactions.
Biochem. Biophys. Res. Commun.
102:243-249[Medline].
|
| 6.
|
Bond, M. D., and H. E. Van Wart.
1984.
Characterization of the individual collagenases from Clostridium histolyticum.
Biochemistry
23:3085-3091[Medline].
|
| 7.
|
Bond, M. D., and H. E. Van Wart.
1984.
Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography.
Biochemistry
23:3077-3085[Medline].
|
| 8.
|
Bond, M. D., and H. E. Van Wart.
1984.
Relationship between the individual collagenases of Clostridium histolyticum: evidence for evolution by gene duplication.
Biochemistry
23:3092-3099[Medline].
|
| 9.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 10.
|
Christianson, D. W., and R. S. Alexander.
1989.
Carboxylate-His-zinc interactions in protein structure and function.
J. Am. Chem. Soc.
111:6412-6419.
|
| 11.
|
Colman, P. M.,
J. N. Jansonius, and B. W. Matthews.
1972.
The structure of thermolysin: an electron density map at 2.3 Å resolution.
J. Mol. Biol.
70:701-724[Medline].
|
| 12.
|
Gomis-Ruth, F. X.,
U. Gohlke,
M. Betz,
V. Knauper,
G. Murphy,
C. Lopez-Otin, and W. Bode.
1996.
The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain.
J. Mol. Biol.
264:556-566[Medline].
|
| 13.
|
Hanahan, D.
1985.
Techniques for transformation of E. coli, p. 109-135.
In
D. M. Glover (ed.), DNA cloning: a practical approach, vol. 1. IRL Press, Oxford, England.
|
| 14.
|
Holden, H. M.,
D. E. Tronrud,
A. F. Monzingo,
L. H. Weaver, and B. W. Matthews.
1987.
Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues.
Biochemistry
26:8542-8553[Medline].
|
| 15.
|
Hooper, N. M.
1994.
Families of zinc metalloproteases.
FEBS Lett.
354:1-6[Medline].
|
| 16.
|
Jung, C.-M.,
O. Matsushita,
S. Katayama,
J. Minami,
I. Ohhira, and A. Okabe.
1996.
Expression of the colH gene encoding Clostridium histolyticum collagenase in Bacillus subtilis and its application to enzyme purification.
Microbiol. Immunol.
40:923-929[Medline].
|
| 17.
|
Kawamura, F., and R. H. Doi.
1984.
Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral protease.
J. Bacteriol.
160:442-444[Abstract/Free Full Text].
|
| 18.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[Medline].
|
| 19.
|
Le Moual, H.,
N. Dion,
B. P. Roques,
P. Crine, and G. Boileau.
1994.
Asp650 is crucial for catalytic activity of neutral endopeptidase 24-11.
Eur. J. Biochem.
221:475-480[Medline].
|
| 20.
|
Li, J.,
P. Brick,
M. C. O'Hare,
T. Skarzynski,
L. F. Lloyd,
V. A. Curry,
I. M. Clark,
H. F. Bigg,
B. L. Hazleman,
T. E. Cawston, and D. M. Blow.
1995.
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
Structure
3:541-549[Medline].
|
| 21.
|
Matsushita, O.,
C.-M. Jung,
S. Katayama,
J. Minami,
Y. Takahashi, and A. Okabe.
1999.
Gene duplication and multiplicity of collagenases in Clostridium histolyticum.
J. Bacteriol.
181:923-933[Abstract/Free Full Text].
|
| 22.
|
Matsushita, O.,
C.-M. Jung,
J. Minami,
S. Katayama,
N. Nishi, and A. Okabe.
1998.
A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase.
J. Biol. Chem.
273:3643-3648[Abstract/Free Full Text].
|
| 23.
|
Matsushita, O.,
K. Yoshihara,
S.-I. Katayama,
J. Minami, and A. Okabe.
1994.
Purification and characterization of a Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene.
J. Bacteriol.
176:149-156[Abstract/Free Full Text].
|
| 24.
|
Mookhtiar, K. A., and H. E. Van Wart.
1992.
Clostridium histolyticum collagenases: a new look at some old enzymes.
Matrix
1(Suppl.):116-126[Medline].
|
| 25.
|
Nishi, N.,
O. Matsushita,
K. Yuube,
H. Miyanaka,
A. Okabe, and F. Wada.
1998.
Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain.
Proc. Natl. Acad. Sci. USA
95:7018-7023[Abstract/Free Full Text].
|
| 26.
|
Okabe, A.,
O. Matsushita,
S. Katayama, and H. Hayashi.
1986.
Lincomycin stimulates synthesis of TEM-2 -lactamase by Escherichia coli.
Antimicrob. Agents Chemother.
30:82-87[Abstract/Free Full Text].
|
| 27.
|
Peterkofsky, B.
1982.
Bacterial collagenase.
Methods Enzymol.
82:453-471.
|
| 28.
|
Reinemer, P.,
F. Grams,
R. Huber,
T. Kleine,
S. Schnierer,
M. Piper,
H. Tschesche, and W. Bode.
1994.
Structural implications for the role of the N terminus in the `superactivation' of collagenases. A crystallographic study.
FEBS Lett.
338:227-233[Medline].
|
| 29.
|
Roques, B. P.,
F. Noble,
V. Dauge,
M. C. Fournié-Zaluski, and A. Beaumont.
1993.
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Pharmacol. Rev.
45:87-145[Medline].
|
| 30.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 31.
|
Seglen, P. O.
1976.
Preparation of isolated rat liver cells.
Methods Cell Biol.
13:29-83[Medline].
|
| 32.
|
Trieu-Cuot, P.,
C. Carlier,
C. Poyart-Salmeron, and P. Courvalin.
1991.
Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria.
Gene
102:99-104[Medline].
|
| 33.
|
Vazeux, G.,
J. Wang,
P. Corvol, and C. Llorens-Cortes.
1996.
Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A.
J. Biol. Chem.
271:9069-9074[Abstract/Free Full Text].
|
| 34.
|
Wünsch, E., and H.-G. Heidrich.
1963.
Zur quantitativen Bestimmung der Kollagenase.
Hoppe-Seyler's Z. Physiol. Chem.
333:149-151[Medline].
|
| 35.
|
Yoshihara, K.,
O. Matsushita,
J. Minami, and A. Okabe.
1994.
Cloning and nucleotide sequence analysis of the colH gene from Clostridium histolyticum encoding a collagenase and a gelatinase.
J. Bacteriol.
176:6489-6496[Abstract/Free Full Text].
|
Journal of Bacteriology, May 1999, p. 2816-2822, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pillai, L., Sha, J., Erova, T. E., Fadl, A. A., Khajanchi, B. K., Chopra, A. K.
(2006). Molecular and Functional Characterization of a ToxR-Regulated Lipoprotein from a Clinical Isolate of Aeromonas hydrophila. Infect. Immun.
74: 3742-3755
[Abstract]
[Full Text]
-
Zamboni, P., De Mattei, M., Ongaro, A., Fogato, L., Carandina, S., De Palma, M., Tognazzo, S., Scapoli, G. L., Serino, M. L., Caruso, A., Liboni, A., Gemmati, D.
(2004). Factor XIII Contrasts the Effects of Metalloproteinases in Human Dermal Fibroblast Cultured Cells. VASC ENDOVASCULAR SURG
38: 431-438
[Abstract]
-
Matsushita, O., Koide, T., Kobayashi, R., Nagata, K., Okabe, A.
(2001). Substrate Recognition by the Collagen-binding Domain of Clostridium histolyticum Class I Collagenase. J. Biol. Chem.
276: 8761-8770
[Abstract]
[Full Text]